PATIENT-REPORTED OUTCOME DATA FROM THE LUX-LUNG 8 PHASE III GLOBAL TRIAL OF AFATINIB VERSUS ERLOTINIB AS SECOND-LINE TREATMENT FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY.

Lee K., GÖKER E., COŞKUN H. Ş., Gordon J., Gadgeel S.

ONCOLOGY NURSING FORUM, cilt.43, sa.2, 2016 (SCI-Expanded)

• Yayın Türü: Makale / Özet
• Cilt numarası: 43 Sayı: 2
• Basım Tarihi: 2016
• Dergi Adı: ONCOLOGY NURSING FORUM
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
• Akdeniz Üniversitesi Adresli: Evet